Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Hongshuo Pharmaceutical Co., Ltd. is a pharmaceutical manufacturing company based in Yichun, Jiangxi Province, China. Established in 2016, the company focuses on the production and sale of traditional Chinese medicines (TCM) and generic pharmaceutical products. Its commercial portfolio includes Bile Grass Tablets for heat-clearing, Oryzanol Double Vitamin B Tablets for nutritional support, and Yiqing Granules for inflammatory conditions. The company operates manufacturing facilities in the Huangjindui Industrial Park and adheres to regional regulatory standards. Despite the 2025 revocation of its registration for Hyoscine Butylbromide Tablets by the National Medical Products Administration, Jiangxi Hongshuo continues to supply a variety of essential medicines to the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Hongshuo Pharmaceutical.